Methionine Capped Nanoparticles as Acetylcholinesterase Inhibitors

The silver and gold L-methionine capped nanoparticles (Ag and Au @LM NPs) were analyzed as prospective acetylcholinesterase (AChE) inhibitors to test their potential in the treatment of cognitive impairment in depression and Alzheimer's disease. The stability of NPs, and their ability to inhibit AChE were studied by UV-Vis and FTIR spectrophotometry. At the same time, TEM and SEM measurements, DLS, and zeta potential measurements were employed in the structural characterization of NPs. Nearly spherical, negatively charged Ag and Au @LM NPs, with 17 nm and 31 nm in diameter, respectively, showed moderate inhibitory potential toward AChE in the given frame of investigated concentrations. For both NPs IC50 is not reached. Furthermore, the adsorption of enzyme molecules on the surface of Ag and Au @LM NPs was demonstrated. Hence, our assumption is that inhibition of AChE is caused by blockage of the enzyme's active site due to the steric hindrance of NPs.

Automated summary

The silver and gold L-methionine capped nanoparticles (Ag and Au @LM NPs) were studied as potential acetylcholinesterase (AChE) inhibitors for treating cognitive impairment in depression and Alzheimer's disease. The stability of NPs and their ability to inhibit AChE were analyzed using UV-Vis and FTIR spectrophotometry. The study found that the negatively charged Ag and Au @LM NPs, with diameters of 17 nm and 31 nm respectively, showed moderate inhibitory potential against AChE.